Spectral AI (MDAI) Competitors $2.53 +0.15 (+6.30%) Closing price 04:00 PM EasternExtended Trading$2.53 +0.00 (+0.16%) As of 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDAI vs. INGN, TLSI, CVRX, NNOX, CV, INFU, SKIN, ELMD, BSGM, and STIMShould you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include Inogen (INGN), TriSalus Life Sciences (TLSI), CVRx (CVRX), Nano-X Imaging (NNOX), CapsoVision (CV), InfuSystem (INFU), Beauty Health (SKIN), Electromed (ELMD), Biosig Technologies (BSGM), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry. Spectral AI vs. Its Competitors Inogen TriSalus Life Sciences CVRx Nano-X Imaging CapsoVision InfuSystem Beauty Health Electromed Biosig Technologies Neuronetics Spectral AI (NASDAQ:MDAI) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends. Does the media prefer MDAI or INGN? In the previous week, Inogen had 1 more articles in the media than Spectral AI. MarketBeat recorded 1 mentions for Inogen and 0 mentions for Spectral AI. Spectral AI's average media sentiment score of 0.00 equaled Inogen'saverage media sentiment score. Company Overall Sentiment Spectral AI Neutral Inogen Neutral Do analysts rate MDAI or INGN? Spectral AI currently has a consensus price target of $3.50, indicating a potential upside of 38.34%. Inogen has a consensus price target of $11.00, indicating a potential upside of 26.58%. Given Spectral AI's higher probable upside, equities research analysts plainly believe Spectral AI is more favorable than Inogen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Inogen 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk & volatility, MDAI or INGN? Spectral AI has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Inogen has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Is MDAI or INGN more profitable? Inogen has a net margin of -7.58% compared to Spectral AI's net margin of -51.97%. Spectral AI's return on equity of 0.00% beat Inogen's return on equity.Company Net Margins Return on Equity Return on Assets Spectral AI-51.97% N/A -8.69% Inogen -7.58%-13.77%-8.52% Do insiders & institutionals have more ownership in MDAI or INGN? 67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 30.7% of Spectral AI shares are owned by insiders. Comparatively, 1.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has higher earnings and valuation, MDAI or INGN? Spectral AI has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectral AI$29.58M2.29-$15.31M-$0.69-3.67Inogen$335.70M0.70-$35.89M-$1.06-8.20 SummarySpectral AI beats Inogen on 7 of the 13 factors compared between the two stocks. Get Spectral AI News Delivered to You Automatically Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDAI vs. The Competition Export to ExcelMetricSpectral AIMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$67.63M$6.97B$6.10B$10.65BDividend YieldN/A1.15%5.70%4.74%P/E Ratio-3.6727.6685.5527.59Price / Sales2.29198.81622.26138.47Price / CashN/A22.0037.7861.77Price / Book-7.915.4513.136.76Net Income-$15.31M$178.04M$3.30B$275.88M7 Day Performance10.48%5.08%5.27%3.71%1 Month Performance35.29%12.65%9.93%10.21%1 Year Performance134.26%35.38%87.76%35.85% Spectral AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDAISpectral AI2.4875 of 5 stars$2.53+6.3%$3.50+38.3%+110.6%$67.63M$29.58M-3.6783Analyst ForecastINGNInogen3.7716 of 5 stars$8.43-2.5%$11.00+30.5%-6.2%$233.90M$335.70M-7.951,030TLSITriSalus Life Sciences2.1 of 5 stars$4.63+0.2%$10.90+135.4%+7.7%$230.39M$29.43M-3.92106Analyst ForecastCVRXCVRx2.6595 of 5 stars$8.73+0.2%$14.00+60.4%+2.2%$227.78M$51.29M-4.16160News CoverageAnalyst ForecastNNOXNano-X Imaging2.1362 of 5 stars$4.13+5.1%$8.50+105.8%-33.7%$227.07M$11.28M-4.59190Analyst ForecastCVCapsoVisionN/A$4.57-4.6%$5.50+20.4%N/A$224.05M$12.52M0.0090Analyst ForecastINFUInfuSystem4.6781 of 5 stars$10.50+1.4%$13.50+28.6%+41.8%$214.47M$139.89M175.03410News CoveragePositive NewsAnalyst DowngradeSKINBeauty Health2.2087 of 5 stars$1.67-0.6%$2.81+68.4%+5.8%$213.07M$334.30M-5.961,030Analyst ForecastGap UpELMDElectromed3.8073 of 5 stars$24.77-1.2%$36.25+46.3%+14.2%$207.47M$64M33.03160BSGMBiosig Technologies1.7856 of 5 stars$6.35+42.6%$10.00+57.6%+2,040.0%$199.35M$13K0.0050Gap DownHigh Trading VolumeSTIMNeuronetics1.3953 of 5 stars$2.83-0.7%$7.00+147.3%+263.8%$188.46M$111.11M-2.50180Analyst Forecast Related Companies and Tools Related Companies INGN Competitors TLSI Competitors CVRX Competitors NNOX Competitors CV Competitors INFU Competitors SKIN Competitors ELMD Competitors BSGM Competitors STIM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDAI) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredAn Early Move On The Next Shift In CoinLitecoin is already processing 500,000+ daily transactions, integrated with PayPal and Revolut, and now one fi...Market Tactic | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
